Sec Form 4 Filing - Reynoso Jamie L. @ CLOVER HEALTH INVESTMENTS, CORP. /DE - 2022-01-07

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Reynoso Jamie L. 2. Issuer Name and Ticker or Trading Symbol CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO of Medicare Advantage (Last) (First) (Middle) C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 LORY LANE, SUITE 210 3. Date of Earliest Transaction (MM/DD/YY) 01/07/2022 (Street) FRANKLIN, TN37067 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 01/07/2022 F 15,830 ( 1 ) D $ 3.16 1,437,766 ( 2 ) D Class A Common Stock 01/07/2023 F 16,369 ( 1 ) D $ 1.01 1,421,397 D Class A Common Stock 01/31/2023 F 1,281 ( 3 ) D $ 1.33 1,420,116 D Class A Common Stock 03/14/2023 F 31,455 ( 4 ) D $ 0.93 1,388,661 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Reynoso Jamie L. C/O CLOVER HEALTH INVESTMENTS, CORP. 3401 LORY LANE, SUITE 210 FRANKLIN, TN37067 CEO of Medicare Advantage Signatures /s/ Joseph R. Martin as attorney-in-fact for Jamie L. Reynoso 04/26/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021. ( 2 )The number of shares of the Issuer's Class A Common Stock reported as beneficially owned includes an adjustment from the most recent Form 4 filing to reflect 1,281 shares of the Issuer's Class A Common Stock withheld by the Issuer to cover the Reporting Person's tax obligations in connection with a prior vesting event that was reported on a Form 4/A filed on the same date as this Form 4 report. ( 3 )Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting of 1/3rd, of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The original grant was timely reported on a Form 4 filed on July 20, 2021. ( 4 )Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on March 14, 2023, of 25% of the original number of RSUs granted to the Reporting Person on March 14, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after March 14, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. The original grant of RSUs was timely reported on a Form 4 filed on Mach 16, 2022.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.